Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Watkins, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Watkins, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management

H. Watkins1

Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, U.K.

1 Correspondence: Hugh Watkins, Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DV, U.K.

Abstract

Molecular genetic research in hypertrophic cardiomyopathy (HCM) has shown that this heart muscle disorder, which was previously considered `idiopathic', is caused by a wide diversity of mutations that affect the cardiac contractile proteins. With this information, it is now possible to explore molecular genetic diagnosis, recalibration of clinical diagnostic tools and criteria, and genotype-phenotype correlations. However, the biggest potential benefit is that a detailed understanding of the disease pathway may lead to disease-modifying treatments. Demonstration of the mutations in cardiac contractile protein genes has focused attention on alterations in contractility. However, no unifying abnormality of contractility is apparent; rather, the defects point to an inefficiency of ATP usage in the sarcomere. The very recent finding of HCM-causing mutations in a regulatory subunit of AMP-activated protein kinase strongly supports the hypothesis that the unifying abnormality in this condition is an inability to maintain normal ATP availability in the myocardium during times of stress. This conclusion should ultimately lead to new approaches to therapy and to further consideration of the role of altered myocardial energetics in other forms of heart muscle disease.

Key Words: AMP kinase • cardiomyopathy • contractile proteins • energetics • genes

References

  1. Geisterfer-Lowrance AAT, Kass S, Tanigawa G, et al. A molecular basis for familial Hypertrophic cardiomyopathy: a ß cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999–1006[CrossRef][Web of Science][Medline]
  2. Thierfelder L, Watkins H, MacRae C, et al. Alpha- tropornyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994;77:701–712[CrossRef][Web of Science][Medline]
  3. Watkins H, McKenna W, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and a-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058–1064[Abstract/Free Full Text]
  4. Watkins H, Conner D, Thierfelder L, et al. Mutations in the cardiac myosin binding protein-C on chromosome 11 cause familial Hypertrophic cardiomyopathy. Nat Genet. 1995;11:434–437[CrossRef][Web of Science][Medline]
  5. Poetter K, Jiang H, Hassanzadeh S, et al. Mutations in either the essential or regulatory light chains are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 1996;13:63–69[CrossRef][Web of Science][Medline]
  6. Kimura A, Harada H, Park JE, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet. 1997;16:379–382[CrossRef][Web of Science][Medline]
  7. Mogensen J, Klausen IC, Pedersen AK, et al. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest. 1999;103:39–43[Web of Science][Medline]
  8. Satoh M, Takahashi M, Sakamoto M, et al. Structural analysis of the titin gene in Hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun. 1999;262:411–417[CrossRef][Web of Science][Medline]
  9. Lankford EB, Epstein ND, Fananapazir L, Sweeney HL. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest. 1995;95:1409–1414
  10. Bottinelli R, Coviello DA, Redwood CS, et al. A mutant tropomyosin that causes hypertrophic cardiomyopathy is incorporated in vivo and associated with an increased calcium sensitivity. Circ Res. 1998;82:106–115[Abstract/Free Full Text]
  11. Watkins H, Seidman CE, Seidman JG, et al. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. J Clin Invest. 1996;98:2456–2461[Web of Science][Medline]
  12. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:775–779
  13. Bonne G, Carrier L, Richard P, et al. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res. 1998;83:580–593[Abstract/Free Full Text]
  14. Niimura H, Bachinski LL, Sangwatanaroj S, et al. Human cardiac myosin binding protein C mutations cause late-onset familial cardiac hypertrophy. N Engl J Med. 1998;338:1248–1257[Abstract/Free Full Text]
  15. McKenna WJ, Spirito P, Desnos M, et al. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart. 1997;77:130–132[Abstract/Free Full Text]
  16. Saumarez RC, Slade AK, Grace AA, et al. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study. Circulation. 1995;91:2762–2768[Abstract/Free Full Text]
  17. Nagueh SF, Kopelen HA, Lim DS, et al. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation. 2000;102:1346–1350[Abstract/Free Full Text]
  18. Blair E, Price SJ, Baty CJ, et al. Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy. J Med Genet. 2001;38:385–388[Free Full Text]
  19. FHC Mutation Database.
  20. Yu B, French JA, Jeremy RW, et al. Counselling issues in familial hypertrophic cardiomyopathy. J Med Genet. 1998;35:183–188[Abstract/Free Full Text]
  21. Watkins H, Rosenzweig A, Hwang DS, et al. Characteristics and prognostic implications of myosin missense mutations in familial Hypertrophic cardiomyopathy. N Engl J Med. 1992;326:1108–1114[Abstract]
  22. Epstein ND, Cohn GM, Cyran F, et al. Differences in clinical expression of Hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A Leu908Val mutation and a Aig403Gln mutation. Circulation. 1992;86:345–352[Abstract/Free Full Text]
  23. MacRae CA, Ghaisas N, Kass S, et al. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest. 1995;96:1216–1220
  24. Varnava A, Baboonian C, Davison F, et al. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart. 1999;82:621–624[Abstract/Free Full Text]
  25. Corfield VA, Moolman JC, Posen B, et al. Sudden death due to troponin T mutations. J Am Coll Cardiol. 1997;29:549–555[Abstract]
  26. Anan R, Shono H, Kisanuki A, et al. Patients with familial hypertrophic cardiomyopathy caused by a Phe10Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation. 1998;98:391–397[Abstract/Free Full Text]
  27. Spirito P, Bellone P, Harris KM, et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778–1785[Abstract/Free Full Text]
  28. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001;104:557–567[CrossRef][Web of Science][Medline]
  29. Kamisago M, Sharma SD, DePalma SR, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000;343:1688–1696[Abstract/Free Full Text]
  30. Sakamoto A, Ono K, Abe M, et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, deltasarcoglycan, in hamster: an animal model of disrupted dys trophin-associated glycoprotein complex. Proc Natl Acad Sci USA. 1997. p. 13873–13878
  31. Gruen M, Gautel M. Mutations in the ß-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin binding protein-C. J Mol Biol. 1999;286:933–949[CrossRef][Web of Science][Medline]
  32. Sweeney HL, Feng HS, Yang Z, Watkins H. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Nail Acad Sci U S A. 1998;95:14406–14410
  33. Redwood CR, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res. 1999;44:20–36[Abstract/Free Full Text]
  34. Bing W, Knott A, Redwood C, et al. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alphatropomyosin (Aspl75Asn and Glul80Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. J Mol Cell Cardiol. 2000;32:1489–1498[CrossRef][Web of Science][Medline]
  35. Elliott K, Watkins H, Redwood CS. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem. 2000;275:22069–22074[Abstract/Free Full Text]
  36. Blair E, Redwood C, Ashrafian H, et al. Mutations in the subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet. 2001;10:1215–1220[Abstract/Free Full Text]
  37. Spindler M, Saupe KW, Christe ME, et al. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest. 1998;101:1775–1783[Web of Science][Medline]
  38. Merante F, Tein I, Benson L, Robinson BH. Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA (glycine) gene. Am J Hum Genet. 1994;55:437–446[Web of Science][Medline]
  39. Puccio H, Koenig M. Recent advances in the molecular pathogenesis of Friedreich ataxia. Hum Mol Genet. 2000;9:887–892[Abstract/Free Full Text]
  40. Bonnet D, Martin D, De Lonlay P, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation. 1999;100:2248–2253[Abstract/Free Full Text]
  41. Hardie DG, Carling D. The AMP-activated protein kinase: fuel gauge of the mammalian cell? Eur J Biochem. 1997;246:259–273[Web of Science][Medline]
  42. Kemp BE, Mitchelhill KI, Stapleton D, et al. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci. 1999;24:22–25[CrossRef][Web of Science][Medline]
  43. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997;96:2190–2216[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Watkins, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Watkins, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?